Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
The highly-anticipated fifth edition is here! Get the must-have resource for achieving compliance with medical device regulations.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Gain a thorough understanding of regulatory affairs for medical devices and IVDs in the U.S. in this intensive, two-day online workshop. Regulatory experts will discuss the laws, regulations, and enforcement and agency structures regulating devices and IVD products. They will review advertising, labeling and promotion post-market, as well as compliance and enforcement requirements. The speakers will also cover FDA guidance, and options and strategies for FDA submissions.
7 December 2021 – 22 February 2022: Early Bird $825.00 Member | $970.00 Nonmember
23 February 2022 – 22 March 2022: Regular $970.00 Member | $1,150.00 Nonmember
This workshop will benefit individuals who are new to the regulatory profession, entering the medical device industry, or changing companies and/or product lines or industry. The material will also be helpful to anyone studying for the RAC Devices exam.
QSR/QMS and Design Control
Instructors:
David Chadwick, PhD, RAC has over 25 years of experience in the medical device industry in such areas as basic research and development, clinical research, and for the past 20 years, regulatory affairs/quality assurance. The scope of his experience includes the product areas of dermatology, in vitro diagnostics, urology, cardiology, ENT devices, drug delivery, electrosurgery, cardiovascular stents and catheters, with many years in research and development functions and managing clinical trials prior to transitioning into regulatory affairs. My primary focus resides in medical devices and combination products, but my experience also expands into drug regulation and submission. He currently serves as the director of regulatory science for Cook Medical, providing high-level regulatory and clinical advice on pre- and post-market safety, quality, performance, testing, compliance, and marketing issues pertaining to medical devices globally.
Christie Hughes has over 25 years of experience in the in vitro diagnostic medical device (IVD) industry. With a degree in clinical laboratory science, she began her career in hospital clinical laboratories. Upon moving into industry, Christie worked in various quality and compliance roles at small and startup companies where she established their quality management systems (QMS) compliant with ISO 9001, ISO 13485, and FDA QSR requirements. To learn other aspects of the industry, Christie led commercial and post-launch phases for a molecular test as a Product Manager before moving into Regulatory Affairs where she developed and executed domestic and international regulatory strategies for IVD instruments, software, and multiplexed assays (protein and molecular). After many years in various roles in industry and earning her master’s in public health degree in epidemiology, Christie moved into consulting where she continues to leverage her experience and knowledge to determine elegant solutions for clients’ QMS and regulatory affairs challenges.
Mark DuVal, J.D., is president and CEO of DuVal & Associates, P.A., a law firm dedicated to counseling companies in the medical device, pharmaceutical, biotech, food, and nutritional supplement industries. His firm provides strategic regulatory advice; handles product pre-submissions as well as filing, negotiating and appealing 510(k)s, de novos, PMAs and the like; works on compliance and enforcement matters; develops compliance programs; designs and implements sophisticated marketing programs; counsels on reimbursement matters; conducts sales training and interfaces extensively on behalf of companies with the FDA with relation to clinical trial negotiations, enforcement negotiations; policy arguments, appeals of all kinds (LB Flag, 21 CFR 10.75, 517A, etc.) and so on. Mark has served on various boards including the Minnesota BioBusiness Alliance, Minnesota Biosciences Council, the Food and Drug Law Institute and has been a former Chairman of the Minnesota State Food, Drug, and Medical Device Section of the Minnesota State Bar Association. He is also on the Board of Advisors of the Masters in Regulatory Affairs and Services Program at St. Cloud State University. He is a frequent contributing speaker/panelist to MMDA, Minnesota Medical Alley, RAPS national and the RAPS Minnesota Chapter and is on the programming committee of the Medtech Investing Conference in Minneapolis.
Tony Blank, CoFounder & Senior Advisor Barton & Blank, LLC
Andrea Gadsby, Director of Quality Assurance Cook Incorporated